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Summary The Wilms' tumour is a solid childhood tumour of the kidney, consisting of blastema, tubules and
mesenchyme. Embryonic tumours, such as Wilms', may arise as a result of a developmental disturbance in
differentiation. The expression of class I and II major histocompatibility complex (MHC) antigens was
investigated on 6 Wilms' tumours and related to that in the developing human kidney in this immunohisto-
logical study, using a panel of monoclonal antibodies.
The Wilms' tumour blastemal cells were class I MHC antigen negative, but differentiated structures were
positive. Class II MHC antigens were not observed in Wilms' tumours. In the developing human kidney class
I MHC antigen expression was observed on glomeruli from 8 weeks and on tubules from 13 weeks gestational
age. Class II MHC antigen expression was observed on glomeruli from 11 weeks and on tubules from 13
weeks gestation. These results suggest that the blastemal cells within the Wilms' tumour may reflect an early
stage of development with respect to the expression of MHC antigens.
The expression of major histocompatibility complex (MHC)
antigens has been widely studied on many types of tumours,
including colonic, breast, gynaecological and renal neoplasms
(Csiba et al., 1984; Whitwell et al., 1984; Ferguson et al.,
1985; Heineman et al., 1987). These studies have attempted
to relate MHC antigen expression to the level of inflam-
matory cell infiltrate within the tumour. These investigations
are frequently based on the proposition that such MHC
antigens may generate a host anti-tumour response. How-
ever, no clear cut relationship between MHC antigen expres-
sion and the inflammatory cell infiltrate has been
consistently demonstrated. Thus the significance of MHC
antigen expression in this context remains unclear.
In addition to their classical immunological functions,
there is now evidence that MHC antigens may also be
implicated in normal tissue development and in the process
of cellular transformation (Brickell et al., 1983; Platt et al.,
1983).
MHC antigen expression on tumour cells arising in adults
can be readily related to the MHC antigen status of their
normal cellular counterparts. However, in the study of
embryonic tumours that arise in children such comparative
studies are more complex, since the ontogeny of MHC
antigen expression during the normal development of many
tissues is unknown.
The Wilms' tumour is a solid childhood kidney tumour
containing undifferentiated tissue, that is thought to corres-
pond to early embryonic renal blastema, tubules and mesen-
chyme (Willis, 1967). Several studies have suggested that
mutant alleles are present on chromosome 11 of Wilms'
tumours (Koufos et al., 1984; Orkin et al., 1984; Reeve et
al., 1984; Fearon et al., 1984) and that the normal gene
product of this locus may be involved in normal kidney
differentiation (Koufos et al., 1985). These studies support
the general theory that embryonic tumours occurring in
children may arise as a developmental disturbance in specific
cellular differentiation pathways within a given tissue (Willis,
1967).
In this study we have investigated immunohistologically
the expression of class I and class II MHC antigens on six
Wilms' tumours, childhood healthy kidney and kidney at
different stages of development, using a panel of monoclonal
antibodies. The expression of MHC antigens on the Wilms'
tumours has been related to that expressed in the developing
kidney, with particular reference to the stage in development
reached by the Wilms' tumour before development is
arrested.
Correspondence: G.M. Borthwick.
Received 30 April 1988; and in revised form, 8 July 1988.
Materials and methods
Tissue
Wilms' tumours (6 cases) and adjacent normal childhood
kidney were obtained from therapeutic nephrectomies. The
pathology reports confirmed the diagnosis of Wilms'
tumour.
Foetal kidney at various stages of development (6-18
weeks) gestation (approximate post-conceptional age) was
obtained from ectopic pregnancies and therapeutic termina-
tions of pregnancy. A total of 37 foetal kidneys were studied;
33 kidneys of 6-13 weeks gestation and 4 mid-gestational
kidneys (14 at 6-7 weeks, 9 at 8-9 weeks, 5 at 10-11 weeks,
5 at 13 weeks, 2 at 17 weeks and 2 at 18 weeks). The
gestational age of the foetal kidney material was determined
from foetal footlength (Moore, 1977). Local ethical com-
mittee permission was obtained to collect these samples.
Adult kidney was obtained within a few hours of death at
post-mortem.
Blocks were taken of all tumour and tissue samples, snap
frozen and stored in liquid nitrogen.
Immunohistology
Cryostat sections (5Mm) were cut, air dried and fixed in
acetone for 10min. An indirect immunoperoxidase method
was used to stain the sections. Serial sections were incubated
with the monoclonal antibodies listed in Table I for 45min.
The slides were then washed in Tris buffered saline pH7.6
(TBS). The antibody binding was detected by incubating the
sections for 30min with peroxidase conjugated rabbit anti-
mouse immunoglobulin (1/50), (Dako Ltd.) in 10% normal
human serum/TBS and then washed in TBS. The sections
were then incubated with the peroxidase substrate diamino-
benzidine tetrahydrachloride (6mg in 10ml TBS and 25,l
3% H202 per 10ml), (Sigma). The reaction was stopped by
washing the slides in tap water. The sections were counter-
stained with haematoxylin, dehydrated, cleared in Histoclear
(National Diagnostics) and mounted in DPX mountant. The
whole procedure was performed at room temperature.
Results
Class I MHC antigen expression on Wilms' tumour
All of the Wilms' tumours investigated in this study
expressed the classical lobular pattern of islands of epithelial
tumour cells surrounded by stroma. Five of the tumours
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Table I Monoclonal antibodies
Monoclonal antibody Specificity Dilution Reference Source
W6/32 HLA A, B,C, 1/500 Barnstable et al. (1978) Sera-Lab.
FMC 16 f2 microglobulin 1/10 Zola et al. (1983) Sera-Lab.
Mel HLA B27, B7, B22 1/200 Ellis et al. (1982) Gift of A.J. McMichael
Ma2.1 HLA A2, B17 1/200 McMichael et al. (1980) Gift of A.J. McMichael
NFK-1 HLA DP,DQ, DR 1/500 Fuggle et al. (1983) Gift of S.V. Fuggle
Epithelial membrane Human milk fat 1/10 Heyderman et al. (1985) Dako Ltd.
antigen (EMA) globule membrane protein
Leu M3 Monocyte/macrophage 1/10 Dimitriu-Bona et al. (1983) Becton-Dickinson
F10-89-4 Leucocyte common antigen 1/500 Dalchau et al. (1984) Serotec
Factor VIII Factor VIII related antigen 1/10 Dako Ltd.
Vimentin Vimentin 1/10 Osborn et al. (1984) Amersham
Cytokeratin Cytokeratin 1/10 Osborn & Weber (1983) Amersham
showed epithelial differentiation but in one specimen there
was no epithelial differentiation. In addition, the degree of
differentiation varied within the individual tumours.
The stromal component and cells within the stromal
matrix of all the tumours expressed class I MHC antigens, as
detected by staining with the monoclonal antibodies for the
monomorphic and polymorphic regions of class I MHC
antigens (W6/32, FMC16, Mel and Ma2.1) (Figure la,b).
The class I MHC antigen expressing cells within the stromal
matrix had a similar distribution to cells expressing the
leucocyte common antigen, detected by the monoclonal
antibody F10-89-4, and the macrophage antigen, detected by
the monoclonal antibody Leu M3. The endothelium
vascularising the tumours and identified by the monoclonal
antibody to factor VIII, also consistently expressed class I
MHC antigens.
The undifferentiated blastema in all the tumours showed
no expression of class I MHC antigens (Figure la,b).
However, of particular interest was the expression of MHC
class I antigens on the epithelial elements within the tumour
(Figure la,b,c). There was no expression of class I MHC
antigens on the blastemal component of any of the speci-
mens (Figure la,b). However, there was a complex distri-
bution of MHC antigen antibody binding in areas of tubular
and glomerular differentiation (Figure la,b,c). Some tubules
were MHC antigen class I positive while others were clearly
negative. Some of the class I MHC antigen positive tubules
also expressed epithelial membrane antigen (EMA), a mole-
cule known to be expressed by distal but not proximal
tubules in the normal adult kidney (Yeger et al., 1985), while
others did not. None of the class I MHC antigen negative
tubules expressed EMA.
Further tubular heterogeneity was apparent using mono-
clonal antibodies to intermediate filament proteins. A mono-
clonal antibody to cytokeratin bound to all elements within
these tumours including blastema and all tubular elements
(Figure 2a). Tubular structures showed relatively increased
binding of the cytokeratin monoclonal antibody used in this
study (Figure 2a). The monoclonal antibody to vimentin also
bound to blastemal cells and some but not all tubules
(Figure 2b). Some tubular structures also clearly expressed
both vimentin and cytokeratin. EMA expressing structures
were a subset of the vimentin negative tubular structures.
The class I MHC antigen expressing tubular structures did
not express vimentin; all vimentin negative tubular structures
appeared to express class I MHC antigens. Glomerular
structures consistently expressed MHC class I antigens,
vimentin and cytokeratin.
Class II MHC antigen expression on Wilms' tumour
Class II MHC antigens were not expressed on any of the
undifferentiated or differentiated epithelial tumour cells or
the stromal matrix. Class II MHC antigen expressing cells
were present throughout the tumours (Figure 3); these cells
had a similar distribution to those expressing the leucocyte
common antigen and the macrophage antigen detected by
the monoclonal antibody Leu M3.
Class I MHC antigen expression on adult kidney and
healthy kidney from Wilms' tumour patients
The expression of class I MHC antigens observed on healthy
kidney adjacent to the Wilms' tumour (Figure 4) and normal
adult kidney in this study was consistent with previously
published reports (Daar et al., 1984a; Fuggle et al., 1983).
The healthy kidney from Wilms' tumour cases had a similar
class I MHC antigen expression to that seen in the adult
kidney. All structures (proximal and distal convoluted
tubules, glomeruli, collecting ducts and blood vessels) present
in the kidneys investigated in this study consistently
expressed class I MHC antigens. The staining intensity for
class I MHC antigens in healthy kidney from Wilms' tumour
cases varied between structures. The staining was very strong
on the glomeruli and interstitial cells in comparison to that
observed on tubular structures.
Class II MHC antigen expression on adult kidney and
healthy kidney from Wilms' tumour patients
The expression of class II MHC antigens on kidney speci-
mens investigated in this study (Figure 5) was consistent with
previously published reports (Daar et al., 1984b; Fuggle et
al., 1983). The class II MHC antigens expression was
heterogeneous; glomeruli (endothelium and mesangium)
expressed class II MHC antigens in all the adult and healthy
kidney from Wilms' tumour patients. The expression of class
II MHC antigens on the tubules was very variable between
specimens.
Class I MHlC antigen expression in developing human kidney
Class I MHC antigen expression was investigated in the
developing human kidney at varying stages, the earliest
specimens of gestational age 6-7 weeks contained collecting
ducts and tubules but not glomeruli; at this stage in develop-
ment these structures did not express class I MHC antigens.
A few class I MHC antigen expressing cells were present
between the developing structures, these cells had a similar
distribution to those detected by the monoclonal antibody to
the leucocyte common antigen.
A few developing glomeruli were observed in the kidney at
approximately 8 weeks gestational age. Although the degree
of differentiation of the glomeruli varied within the speci-
men. Relatively undifferentiated glomeruli did not express
class I MHC antigens whereas differentiated glomeruli
expressed class I MHC antigens. At this stage in develop-
ment of the kidney there were also class I MHC antigen
expressing cells present between the developing structures;
these cells remain on through development. It is interesting
to note that the collecting ducts and tubules did not express
class I MHC antigens at this stage in development.
This pattern of class I MHC antigen expression persisted
until 12 weeks of gestation. At -13 weeks gestational age
class I MHC antigen expression was also observed on a few
('10%) tubular structures (Figure 6). This expression was
very weak in comparison to that observed in the childhood
kidney (Figure 4). By 18 weeks of gestation this weakMHC ANTIGEN EXPRESSION IN WILMS' TUMOUR AND FOETAL KIDNEY 755
Figure 1 Areas of Wilms' tumour stained for class I MHC antigens with the monoclonal antibody W6/32, which showed (a)
differentiated class I MHC antigen expressing structures (arrows) within islands of negative blastemal cells (x 40), (b) rosetting
structures which did not express Class I MHC antigens (x 40) (arrows) and (c) a class I MHC antigen expressing structure
( x400).756 G.M. BORTHWICK et al.
Figure 2 Wilms' tumour stained on serial sections with monoclonal antibodies to the intermediate filament proteins (a)
cytokeratin (x40) and (b) vimentin (x40). All cells within the tumour expressed cytokeratin; the intensity of staining was
increased on differentiated structures. All the cells within the tumour expressed vimentin, apart from a few tubular structures. A
few tubular structures expressed both vimentin and cytokeratin.
Figure 3 Class II MHC antigen expression, detected by the monoclonal antibody NFK-l on Wilms' tumour ( x40). The tumour
cells, differentiated and undifferentiated, were class II MHC antigen negative. Class II MHC antigen expressing cells were present
throughout the tumour; these cells had a similar distribution to those expressing the leucocyte common antigen and a macrophage
marker.MHC ANTIGEN EXPRESSION IN WILMS' TUMOUR AND FOETAL KIDNEY 757
Figure 4 Class I MHC antigen expression on an area of healthy kidney taken from a Wilms' tumour patient, detected by the
monoclonal antibody W6/32 ( x 40). All cells present in the kidneys investigated expressed class I MHC antigens.
Figure 5 Class II MHC antigen expression on an area of healthy kidney taken from a Wilms' tumour patient, detected by the
monoclonal antibody NFK-l (x40). Class II MHC antigen expression was present on all glomeruli, the expression on tubular
structures was variable between specimens.
Figure 6 Class I MHC antigen expression on a developing kidney of 13 weeks gestational age, detected using the monoclonal
antibody W6/32 ( x40). Class I MHC antigen expression was observed on the developing glomeruli, interstitial cells and a few
tubular structures (arrows).758 G.M. BORTHWICK et al.
Figure 7 Class I MHC antigen expression on a developing kidney of 18 weeks gestational age, detected using the monoclonal
antibody W6/32. (a) Class I MHC antigen expression was observed on interstitial cells and -25% of tubules ( x 40) (arrows) and
(b) Class I MHC antigen expression on a tubule ( x400).
expression of Class I MHC antigens increased to - 25% of
tubular structures (Figure 7a,b). A subset of these class I
MHC antigen positive tubular structures also expressed the
antigen detected by the monoclonal antibody EMA. Between
13 and 18 weeks gestation the majority of developing
glomeruli expressed class I MHC antigens.
Class II MHC antigen expression in developing human kidney
Until approximately 11 weeks gestation all structures within
the developing kidney did not express class II MHC anti-
gens. At this stage some but not all of the developing
glomeruli expressed class II MHC antigens (Figure 8a),-the
tubular structures were class II MHC antigen negative.
By - 13-18 weeks gestation, however, a few tubular
structures (<10% by 18 weeks) clearly expressed class II
MHC antigens (Figure 8b). Although this staining pattern
was very weak in comparison to that seen in the childhood
kidney (Figure 5). As with class I MHC antigens a subset of
the class II MHC antigen expressing tubular structures
expressed the antigen detected by the monoclonal antibody
EMA, which is thought to detect distal tubules and collec-
ting ducts in the adult kidney. Class II MHC antigen
expression was still observed on some of the developing
glomeruli and on interstitial cells at a gestational age of 13-
18 weeks. Class II MHC antigen expressing interstitial cells
which were present from a gestational age of 8 weeks had a
similar distribution to cells detected by the monoclonal
antibody to the leucocyte common antigen and cells express-
ing the macrophage antigen detected by the monoclonal
antibody Leu M3.
Discussion
The classical picture of the development of the kidney is that
the tubules are derived from the metanephric mass of
mesoderm (Saxen, 1987). Thus the metanephric tubule
becomes an epithelial structure. The glomeruli are also
derived from the metanephric blastema. The collecting ducts
in the normal kidney are derived from the ureteric bud. The
differentiation pathway of cells within the developing kidney
can be followed by investigating the expression of theMHC ANTIGEN EXPRESSION IN WILMS' TUMOUR AND FOETAL KIDNEY 759
Figure 8 Class II MHC antigen expression detected by the monoclonal antibody NFK-l on developing kidney of (a) 11 weeks
(x 40) and (b) 18 weeks gestational age (x 40). A few class II MHC antigen expressing interstitial cells were present at 11 weeks.
Also, at this stage some of the developing glomeruli expressed class II MHC antigens. At 18 weeks gestational age class II MHC
antigens were detected on interstitial cells, developing glomeruli and - 10% of tubules.
intermediate filaments vimentin and cytokeratin, which are
expressed by mesenchymal and epithelial cells respectively
(Bachmann et al., 1983; Holthofer et al., 1983). In this study
we have followed the differentiation of structures within the
developing kidney by studying the expression of class I and
II MHC antigens. Class I MHC antigens are not expressed
on glomeruli until 8 weeks, and on tubular structures until
13 weeks gestational age. The class II MHC antigen expres-
sion on foetal kidney develops later than class I MHC
antigens on glomeruli, at 11 weeks gestational age, but at
approximately the same gestational age of 13 weeks on
tubular structures. Thus, a clear onset of the expression of
these antigens was observed. However, the significance of the
timing of this onset and the function of the MHC antigens
observed at this stage in development remains unclear.
The majority of cells within the Wilms' tumours comprise
undifferentiated blastemal cells. These cells did not express
either class I or II MHC antigens. This suggests that the
majority of tumour cells may reflect a very early stage of
differentiation with respect to the expression of MHC anti-
gens. Class I MHC antigen expression was observed on some
but not all of the differentiated tubular and glomerular
structures within the tumours. Class II MHC antigen expres-
sion was not observed on any of the differentiated structures.
This pattern of MHC antigen expression is consistent with
the possibility that the tubular like structures, which are a
heterogeneous population within the tumour, have differen-
tiated to a varying degree with respect to class I MHC
antigen expression. Some of the tubular structures within the
Wilms' tumours may reflect an earlier stage of differentiation
than others. This is similar to the pattern seen in the
developing kidney of structures at different stages of
development.
This heterogeneity of antigen expression on differentiating
structures in Wilms' tumours can also be detected using
monoclonal antibodies to the intermediate filament proteins
(Denk et al., 1985; Yeger et al., 1985; Altmannsberger et al.,
1984). The class I MHC antigen expressing tubules observed
in this study of Wilms' tumours express cytokeratin alone.
The tubular structures in this present study which do not
express class I MHC antigens co-express cytokeratin and
vimentin. This differential expression of intermediate fila-
ments may reflect, along with the class I MHC antigen
expression, the progression along the normal differentiation760 G.M. BORTHWICK et al.
pathway of the tubules within the Wilms' tumour. The most
mature tubules express class I MHC antigens and cyto-
keratin, a subset of these express EMA which is a marker
for distal convoluted tubules and collecting ducts. The
tubules in the kidney are derived from the metanephric mass
of mesoderm, which accounts for their expression of vimen-
tin (Saxen, 1987). The metanephric tubule develops into an
epithelial structure, and during this phase, co-expression of
cytokeratin and vimentin may be observed. When cyto-
keratin alone is expressed by the tubule, it has become an
epithelial structure, and it is at this stage that class I MHC
antigen expression is observed.
The corresponding expression of class II MHC antigens
between Wilms' tumours and developing kidney was not
observed. The differentiated structures within the Wilms'
tumours were class II MHC antigen negative. Thus, whereas
glomeruli and tubules in normal foetal kidney expressed class
II MHC antigens from approximately 11 and 13 weeks
respectively, the structures within the Wilms' tumours were
invariably negative. Thus, class II MHC antigen expression
on Wilms' tumours did not reflect that observed in normal
developing kidney. The significance of this lack of class II
MHC antigen expression is not understood.
There is now evidence that as well as having an immune
function, MHC antigens may have a non-immune function
(Edidin, 1983). MHC antigens are thought to play a role in
cellular recognition and interaction. It is difficult to perceive,
although it is possible that MHC antigens detected on the
structures of developing foetal kidney have a classical
immunological role. However, it may be that in this situation
the MHC antigens are necessary for cell communication and
thus for normal development to occur.
The metastatic properties of some tumours may be related
to the level of expression of class I MHC antigens (Katzav et
al., 1984). Transfection of the mouse MHC class I gene into
a mouse fibrosarcoma abolished the metastatic properties of
the tumour (Wallich et al., 1985); the tumour associated
antigens presented along with MHC class I antigens may
facilitate a host response. Studies on neuroblastoma have
shown that the tumour has low levels of expression of class I
MHC antigens and high levels of expression of the myc gene
family (Trowsdale et al., 1980; Schwab et al., 1983). It has
been proposed that there is a relationship between the level
of N-myc and class I MHC antigen expression (Bernards et
al., 1986); transfer of the N-myc gene into a rat neuro-
blastoma cell line led to a decrease in the class I MHC
antigen expression, increased the growth rate and increased
the metastatic capability of the cells. Studies on Wilms'
tumours by Northern blotting and in situ hybridisation of
mRNA have shown that there are elevated levels of N-myc
in this tumour type, located in the blastemal cells (Shaw et
al., 1988). The study presented here shows that these blaste-
mal cells do not express MHC antigens. It may be that in
Wilms' tumours N-myc inhibits the expression of class I
MHC antigens on the blastemal cells, thus maintaining their
metastatic capabilities.
A recent report has demonstrated that the retinoblastoma
susceptibility gene encodes a nuclear phosphoprotein asso-
ciated with DNA binding activity (Lee et al., 1987). This
gene is absent in retinoblastoma; normally the gene product
regulates other genes within the cell, which implies that it is
necessary for normal development to occur. This evidence
supports the theory that childhood tumours arise from a
disturbance along the normal developmental pathway
(Willis, 1967).
In this study we have clearly demonstrated that the
majority of cells within the Wilms' tumour may reflect an
early stage of differentiation with respect to the expression of
MHC antigens. These results, therefore, support the theory
that embryonic tumours arise as a result of a disturbance in
specific cellular differentiation.
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